Moreover, we also explored the molecular mechanisms of IER3 underlying HCC and predicted the TFs that could bind to the IER3 promoter region, so as to ultimately broaden our understanding of IER3 in the incidence and progression of HCC. Here, IER3 is linked to hepatocellular carcinoma.